학술논문
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
Document Type
Article
Author
Source
In: Investigational New Drugs . (Investigational New Drugs, October 2022, 40(5):1087-1094)
Subject
Language
English
ISSN
15730646
01676997
01676997